Reply
- PMID: 34951716
- DOI: 10.1002/hep.32303
Reply
Comment on
-
Optimizing hepatitis B virus screening in the United States using a simple demographics-based model.Hepatology. 2022 Feb;75(2):430-437. doi: 10.1002/hep.32142. Epub 2021 Dec 7. Hepatology. 2022. PMID: 34496066
-
Letter to the editor: Importance of universal screening for chronic hepatitis B infection in adults in the United States.Hepatology. 2022 Apr;75(4):1062-1063. doi: 10.1002/hep.32304. Epub 2022 Jan 8. Hepatology. 2022. PMID: 34951931 No abstract available.
References
-
- Ramrakhiani NS, Chen VL, Le M, Yeo YH, Barnett SD, Waljee AK, et al. Optimizing hepatitis B virus screening in the United States using a simple demographics‐based model. Hepatology. 2021 Sep 8. https://doi.org/10.1002/hep.32142 . [Epub ahead of print] - DOI
-
- Yeo YH, Nguyen MH. Review article: current gaps and opportunities in HBV prevention, testing and linkage to care in the United States—a call for action. Aliment Pharmacol Ther. 2021;53:63–78.
-
- Hutton DW, Tan D, So SK, Brandeau ML. Cost‐effectiveness of screening and vaccinating Asian and Pacific Islander adults for hepatitis B. Ann Intern Med. 2007;147:460–9.
-
- Toy M, Hutton D, Harris AM, Nelson N, Salomon JA, So S. Cost‐effectiveness of one‐time universal screening for chronic hepatitis B infection in adults in the United States. Clin Infect Dis. 2021 May 6. https://doi.org/10.1093/cid/ciab405 . [Epub ahead of print] - DOI
-
- Wu Y, Johnson KB, Roccaro G, Lopez J, Zheng H, Muiru A, et al. Poor adherence to AASLD guidelines for chronic hepatitis B management and treatment in a large academic medical center. Am J Gastroenterol. 2014;109:867–75.

